INTERNATIONAL PATENT: ARROWHEAD PHARMACEUTICALS, INC. FILES APPLICATION FOR "RNAI AGENTS FOR INHIBITING EXPRESSION OF YELLOW FEVER VIRUS (YFV) VIRAL GENOME EXPRESSION"

GENEVA, Feb. 11 -- ARROWHEAD PHARMACEUTICALS, INC. (177 East Colorado BoulevardSuite 700Pasadena, California 91105) filed a patent application (PCT/US2025/039837) for "RNAI AGENTS FOR INHIBITING EXPRESSION OF YELLOW FEVER VIRUS (YFV) VIRAL GENOME EXPRESSION" on Jul 30, 2025. With publication no. WO/2026/030427, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZANDI, Keivan (17351 St. Andrews DrivePoway, California 92064), SAEIDI, Alireza (9858 Graduate DrivewayUnit 103San Diego, California 92131), WINTER, Audra (Arrowhead ...